首页 | 本学科首页   官方微博 | 高级检索  
   检索      

核不均一核糖核蛋白R基因沉默抑制非小细胞肺癌细胞恶性转化
引用本文:刘玲玲,苟铉婧,桂书琴,何小凤,王琴容,谢渊,赵艳,周建奖.核不均一核糖核蛋白R基因沉默抑制非小细胞肺癌细胞恶性转化[J].中国生物化学与分子生物学报,2022,38(12):1640-1650.
作者姓名:刘玲玲  苟铉婧  桂书琴  何小凤  王琴容  谢渊  赵艳  周建奖
作者单位:地方病与少数民族疾病教育部重点实验室;贵州医科大学基础医学院分子生物学重点实验室, 贵阳 550004
基金项目:国家自然科学基金(No.81660474); 贵州省科技计划基础研究项目(No.黔科合基础ZK[2022]重点041)和贵州医科大学国家自然科学基金培育项目(No.19NSP009)资助
摘    要:核不均一核糖核蛋白R(hnRNPR)是一种与mRNA生物学功能密切相关的RNA结合蛋白质,与多种肿瘤细胞的恶性转化相关。然而,在非小细胞肺癌(NSCLC)中的作用机制尚不清楚。本研究通过检索公共数据库发现,hnRNPR蛋白主要在肺癌细胞核中表达,hnRNPR mRNA在非小细胞肺癌组织中高表达,并且与肺腺癌患者的生存率呈负相关;hnRNPR的表达与非小细胞肺癌患者的性别、T分期显著相关(P<0.05)。构建hnRNPR基因沉默的非小细胞肺癌稳定细胞株,检测细胞功能变化,结果显示,hnRNPR基因沉默抑制了细胞增殖、迁移和侵袭能力以及上皮-间质转化(EMT),并将细胞周期阻滞在G1期(P<0.01)。生物信息学分析显示,非小细胞肺癌中hnRNPR基因与9 310个基因的表达正相关(皮尔逊相关系数>0,P<0.05),与10 680个基因的表达负相关(皮尔逊相关系数<0,P<0.05)。综上所述,hnRNPR在非小细胞肺癌中高表达,可能作为剪接体的组分,通过调节相关基因的表达,促进了NSCLC细胞的恶性转化。

关 键 词:核不均一核糖核蛋白R  非小细胞肺癌  增殖  迁移  侵袭  上皮间质转化  
收稿时间:2022-05-25

Heterogeneous Nuclear Ribonucleoprotein R (hnRNPR) Gene Silencing Inhibits the Malignant Transformation of Non-small-cell Lung Cancer Cells
LIU Ling-Ling,GOU Xuan-Jing,GUI Shu-Qin,HE Xiao-Feng,WANG Qin-Rong,XIE Yuan,ZHAO Yan,ZHOU Jian-Jiang.Heterogeneous Nuclear Ribonucleoprotein R (hnRNPR) Gene Silencing Inhibits the Malignant Transformation of Non-small-cell Lung Cancer Cells[J].Chinese Journal of Biochemistry and Molecular Biology,2022,38(12):1640-1650.
Authors:LIU Ling-Ling  GOU Xuan-Jing  GUI Shu-Qin  HE Xiao-Feng  WANG Qin-Rong  XIE Yuan  ZHAO Yan  ZHOU Jian-Jiang
Institution:Key Laboratory of Endemic and Ethnic Diseases, Guizhou Medical University, Ministry of Education;Key Laboratory of Molecular Biology, School of Basic Medicine, Guizhou Medical University, Guiyang 550004, China
Abstract:Heterogeneous nuclear ribonucleoprotein R (hnRNPR) is an RNA-binding protein closely related to the biological function of mRNA, which is involved in the malignant transformation of various tumor cells. However, the role and mechanism of hnRNPR in non-small-cell lung cancer (NSCLC) are still unclear. In this study, the database analysis shows that hnRNPR is mainly expressed in the nucleus of lung cancer cells. Moreover, compared with the normal lung tissues, the mRNA expression of hnRNPR was higher in NSCLC tissues, which was negatively correlated with the survival rate of lung adenocarcinoma (LUAD) patients and significantly related to the gender and T stage of NSCLC patients (P<0.05). Two stable NSCLC cell lines with the hnRNPR gene silenced were constructed. Then cell function assays have indicated that hnRNPR silencing inhibited cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) and arrested the cell cycle at the G1 phase (P<0.01). The bioinformatics analysis has shown that the mRNA expression of hnRNPR in NSCLC was positively correlated with the expressions of 9 310 genes (Pearson correlation coefficient>0, P<0.05), and negatively with 10 680 genes (Pearson correlation coefficient<0, P<0.05). In conclusion, the expression of hnRNPR is upregulated in NSCLC, which may promote the malignant transformation of NSCLC cells by regulating the expression of related genes as a component of spliceosome.
Keywords:heterogeneous nuclear ribonucleoprotein R(hnRNPR)  non-small-cell lung cancer(NSCLC)  cell proliferation  migration  invasion  epithelial-mesenchymal transition(EMT)  
点击此处可从《中国生物化学与分子生物学报》浏览原始摘要信息
点击此处可从《中国生物化学与分子生物学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号